VildagliptinDPP-4 Inhibitor (Antidiabetic Preparations) Indication: ViglitaTM is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus. Dosage & Administration: The recommended dose of ViglitaTM is 50 mg or 100 mg daily for monotherapy; 50 mg twice daily (morning and evening) when used in dual combination with Metformin […]
Vildagliptin + MetforminDPP-4 Inhibitor’s combination (Antidiabetic Preparations) Indication: Management of type 2 diabetes mellitus. Dosage & Administration: Adults: Based on the patient’s current dose of Metformin, Combination of Vildagliptin & Metformin may be initiated at either 50 mg/500 mg or 50 mg/850 mg twice daily, 1 tab in the morning and the other in the […]
SitagliptinDPP-4 Inhibitor (Antidiabetic Preparations) Indication: Management of type 2 diabetes mellitus. Dosage & Administration: The recommended dose of Siglita™ is 100 mg once daily. Siglita™ can be taken with or without food.For patients with mild renal insufficiency (creatinine clearance [CrCl] 50 mL/min) no dosage adjustment for Siglita™ is required.For patients with moderate renal insufficiency (CrCl 30 to <50 […]
Insulin AspartAnalog Insulin (Antidiabetic Preparations) Indication: Type 1 and Type 2 Diabetes Mellitus, Gestational Diabetes Mellitus. Dosage & Administration: =RapilogTM has a faster onset of action, RapilogTMshould generally be given immediately before a meal. When necessary RapilogTM may be given soon after a meal. Dosage of RapilogTM is individual and determined on the basis of the physician’s advice […]
LinagliptinDPP-4 Inhibitor (Antidiabetic Preparations) Indication: Management of type 2 diabetes mellitus. Dosage & Administration: The recommended dose of Linita™ is one tablet once daily. No dosage adjustment is required in patients with type 2 diabetes having renal or hepatic impairment Preparation: Linita™ Tablet: Box containing 30 tablets in blister pack.
Linagliptin and Metformin HydrochlorideDPP-4 Inhibitor’s combination (Antidiabetic Preparations) Indication: LiglimetTM is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both Linagliptin and Metformin is appropriate. Dosage & Administration: Dose of this combination should be individualized on the basis of the patient’s current […]
Insulin GlargineAnalog Insulin (Antidiabetic Preparations) Indication: Type 1 and Type 2 Diabetes Mellitus. Dosage & Administration: Larsulin™ exhibits a relatively constant glucose-lowering profile over 24 hours that permits once-daily dosing. Potency of insulin glargine is approximately the same as human insulin.Larsulin™ is recommended for once daily subcutaneous administration & may be administered at any time […]
Empagliflozin and Metformin HydrochlorideSGLT2 Inhibitor’s combination (Antidiabetic Preparations) Indication: EmjardTM M is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. Dosage & Administration: Initial Dose: Empagliflozin 10 mg/day and Metformin Hydrochloride 1000 mg/day after meal.If Glycemic Target not achieved: Empagliflozin 25 mg/day and Metformin Hydrochloride 1000 […]
EmpagliflozinSGLT2 Inhibitor (Antidiabetic Preparations) Indication: • Emjard™ is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes (T2DM).• Emjard™ is also indicated to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease. Dosage & Administration: The recommended dose of […]